ENSGHealthcare · Medical Care FacilitiesThe 5 Wall Street analysts covering The Ensign Group, Inc. hold a median 12-month price target of $225 — +33.0% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 63 of 100 as at 6 Oct 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores The Ensign Group, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Volatility (96): The share price has been relatively steady.
Accruals (32): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.
Size (15): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on ENSG, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +33.0% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 30 July 2026 | Truist Securities | Maintains | Hold | $202 → $207 |
| 14 July 2026 | Truist Securities | Maintains | Hold | $215 → $202 |
| 14 July 2026 | Truist Securities | Maintains | Hold | — |
| 9 Feb 2026 | RBC Capital | Maintains | Outperform | — |
| 6 Feb 2026 | Truist Securities | Maintains | Hold | — |
| 14 Nov 2025 | RBC Capital | Maintains | Outperform | — |
| 10 Nov 2025 | Truist Securities | Maintains | Hold | — |
| 5 Nov 2025 | Stephens & Co. | Maintains | Overweight | — |
| 5 Nov 2025 | UBS | Maintains | Buy | — |
| 2 Sept 2025 | UBS | Maintains | Buy | — |
| 14 Aug 2025 | UBS | Maintains | Buy | — |
| 28 July 2025 | Stephens & Co. | Maintains | Overweight | — |
| 28 July 2025 | Truist Securities | Maintains | Hold | — |
| 2 May 2025 | Macquarie | Maintains | Outperform | — |
| 7 Feb 2025 | Stephens & Co. | Maintains | Overweight | — |
| 6 Feb 2025 | Stephens & Co. | Reiterates | Overweight | — |
| 4 Feb 2025 | Macquarie | Maintains | Outperform | — |
| 6 Jan 2025 | Truist Securities | Maintains | Hold | — |
| 21 Nov 2024 | UBS | Initiates | Buy | — |
| 28 Oct 2024 | RBC Capital | Maintains | Outperform | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ENSG appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 7 Oct 2026, The Ensign Group, Inc. returned −4.0% against +17.4% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 28% of US stocks
Cheaper than 54% of US stocks
Cheaper than 24% of US stocks
Cheaper than 15% of US stocks
Higher than 66% of US stocks
Higher than 56% of US stocks
Higher than 16% of US stocks
Higher than 62% of US stocks
Higher than 64% of US stocks
Higher than 77% of US stocks
Higher than 79% of US stocks
Higher than 62% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
The Ensign Group, Inc. has a market value of $10.0B and an enterprise value of $11.9B.
Revenue in the twelve months to 30 June 2026: $5.5B. The latest quarter grew 17.3% year on year.
Net income over the same four quarters: $379.0M, a 6.9% net margin.
Diluted earnings per share, trailing twelve months: $6.38.
Free cash flow in the twelve months to 30 June 2026: $419.1M.
The Ensign Group, Inc. spent $41.3M on share buybacks and $14.8M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 27.0×; forward P/E: 20.1× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.15%, paying out 4% of earnings.
The Ensign Group, Inc. employs 46,000 people — $119K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own The Ensign Group, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Cedar Grove Capital said it closed its short position in The Ensign Group during the quarter, alongside several other short positions.
Why it matters — The update reports that Cedar Grove Capital exited a short position in ENSG, a portfolio change relevant to investors tracking the company.
Kaplan Fox & Kilsheimer LLP said it is investigating potential securities violations involving The Ensign Group, Inc. The firm invited investors who suffered losses or have relevant information to contact it.
Why it matters — ENSG watchers may note the announced investigation and its request for investor contact.
Ensign expanded its operations across Florida, Washington and Colorado. The item says strong liquidity and operating cash flow support room for additional acquisitions.
Why it matters — ENSG watchers may note the geographic expansion alongside the company’s stated financial flexibility for further acquisitions.
Diversified Healthcare Trust announced a new 15-year triple-net lease with Ensign operating subsidiaries for seven Colorado skilled nursing facilities with 807 licensed units, effective October 1, 2026. Ensign guaranteed the lease.
Why it matters — The agreement adds a long-term lease commitment for Ensign involving a Colorado portfolio of seven skilled nursing facilities.
Zacks Investment Research highlights The Ensign Group (ENSG) as a strong value stock, using its Zacks Style Scores framework to identify the company among potentially market-beating investment options.
Why it matters — ENSG watchers would note the favorable value-stock designation from a research firm, which may influence how the company is perceived in the market.
The 5 Wall Street analysts covering The Ensign Group, Inc. have a median 12-month price target of $225, with estimates ranging from $207 to $230. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 5 analysts covering The Ensign Group, Inc., 4 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks The Ensign Group, Inc. 63 out of 100 across roughly 4,600 US stocks as at 6 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 6 Oct 2026, The Ensign Group, Inc. ranks 63 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (96 of 100).
No one can know that. What the data says: the median 12-month target from 5 analysts implies +33.0% from the last close, and Ticker Nerd's factor model ranks The Ensign Group, Inc. 63 out of 100 as at 6 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering The Ensign Group, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ENSG are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $207 to $230 over the next 12 months.
The Ensign Group, Inc. returned -4.0% over the 12 months to 7 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
The Ensign Group, Inc. is a healthcare services holding company that provides post-acute care through independent operating subsidiaries.
The most recent item we track (Seeking Alpha, 7 Oct 2026): "Cedar Grove Capital Q3 2026 Portfolio Update". Cedar Grove Capital said it closed its short position in The Ensign Group during the quarter, alongside several other short positions.
The Ensign Group, Inc. is a healthcare services holding company that provides post-acute care through independent operating subsidiaries. The company focuses on skilled nursing, rehabilitation, and senior living services, including physical, occupational, and speech therapy, as well as related healthcare support services. It also operates ancillary businesses such as mobile diagnostics and medical transportation, and it acquires, leases, and owns healthcare real estate tied to the post-acute care continuum. The Ensign Group serves patients and residents across multiple U.S. states through a decentralized operating model, making it a notable participant in skilled care, long-term care, and healthcare property services. Headquartered in San Juan Capistrano, California, and founded in 1999, The Ensign Group plays a significant role in delivering care for aging and medically complex populations.
CEO Mr. Barry R. Port · 46,000 employees · United States · https://ensigngroup.net
